46 results
8-K
EX-99.1
VRCA
Verrica Pharmaceuticals Inc
8 Jan 24
Regulation FD Disclosure
8:01am
of (1) (2) are not using the drug was covered (1) Pompei DT et al. Cantharidin Therapy: Practice patterns and attitudes of health care providers
8-K
EX-99.1
VRCA
Verrica Pharmaceuticals Inc
27 Jul 23
Regulation FD Disclosure
4:15pm
if Available Pompei DT et al. Cantharidin Therapy: Practice patterns and attitudes of health care providers. Journal of the American Academy
8-K
EX-99.1
VRCA
Verrica Pharmaceuticals Inc
24 Jul 23
Regulation FD Disclosure
7:31am
to the approximately 500 patients and their caregivers who participated in the pivotal Phase 3 trials as well as the investigators and health care professionals
8-K
EX-99.1
uwep8l55rhq
14 Sep 22
Regulation FD Disclosure
8:09am
8-K
EX-1.1
m3b4pn37be 6poru5
1 Jul 22
Verrica Announces Proposed Public Offering of Common Stock
8:30am
8-K
EX-99.1
6je 5o077o6
7 Apr 22
Regulation FD Disclosure
4:17pm
8-K
EX-99.1
z4pno7081651ntx8
29 Nov 21
Regulation FD Disclosure
5:07pm
8-K
EX-99.1
qmz3o5he xmtlbo
29 Sep 21
Regulation FD Disclosure
4:06pm
8-K
EX-1.1
3xlk8r75p2vvs9
23 Mar 21
Verrica Announces Proposed Public Offering of Common Stock
5:19pm
8-K
EX-99.1
210biy pfs321ve5b
6 Jan 21
Regulation FD Disclosure
6:05am
8-K
EX-99.2
w4eu rgpe
10 Nov 20
Regulation FD Disclosure
7:52am